Department of Diagnostic Imaging, Hospital for Sick Children, 555 University Ave., Toronto, Ontario, M5G 1X8, Canada.
Division of Pediatric Imaging, Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
Pediatr Radiol. 2022 Mar;52(3):483-492. doi: 10.1007/s00247-021-05221-6. Epub 2021 Dec 2.
Dynamic contrast-enhanced magnetic resonance imaging (MRI) of the liver in pediatric Fontan patients often shows peripheral reticular areas of hypoenhancement, which has not been studied in detail.
To semiquantitatively score the hepatic MR perfusion abnormality seen in pediatric Fontan patients, and to correlate the perfusion abnormality with functional clinical and hemodynamic parameters.
All children (< 18 years old) after Fontan palliation with combined clinical cardiac and liver MRI performed between May 2017 and April 2019 were considered for inclusion. A semiquantitative perfusion score was used to assess the severity of the hepatic reticular pattern seen on dynamic contrast-enhanced liver imaging. The liver was divided into four sections: right posterior, right anterior, left medial and left lateral. Each liver section was assigned a score from 0 to 4 depending on the amount of abnormal reticular hypoenhancement. Scoring was assigned for each section of the liver across eight successive dynamic contrast-enhanced modified spoiled gradient echo runs. Scores were correlated with clinical and hemodynamic parameters.
All Fontan children showed hepatic reticular hypoenhancement by MRI, most severe in the early portal venous phase with a median maximum total perfusion abnormality score of 12 (range: 9-14). All perfusion abnormalities progressively resolved during the hepatic venous phase. Perfusion abnormality scores were greatest in the right compared to left hepatic lobes (7 range: [6-8] vs. 5 [range: 3-6], P < 0.01). The maximum left hepatic lobe perfusion abnormality scores were greatest in children with versus without imaging signs of portal hypertension (8 [range: 7-8] vs. 4 [range: 3-5], P < 0.01). High unconjugated bilirubin and low platelets correlated with greater perfusion abnormality (R = 0.450, P = 0.024, and R = - 0.458, P < 0.01, respectively). Age at MRI, time from Fontan, focal liver lesions and cardiac MRI hemodynamic parameters did not show significant correlations with the severity of the liver perfusion abnormality.
All Fontan children have hepatic reticular hypoenhancement abnormalities seen with MRI that are most severe in the right hepatic lobe and universally show gradual resolution through the hepatic venous phase. Perfusion abnormality in the left hepatic lobe is worse in children with portal hypertension.
儿科法洛四联症患者的动态对比增强磁共振成像(MRI)常显示周边网状低增强区域,但尚未对此进行详细研究。
半定量评分儿科法洛四联症患者的肝脏 MRI 灌注异常,并将灌注异常与功能临床和血流动力学参数相关联。
所有 2017 年 5 月至 2019 年 4 月期间行法洛四联症姑息术后联合心脏和肝脏 MRI 检查的儿科患者均考虑纳入研究。采用半定量灌注评分法评估动态对比增强肝脏成像上肝网状模式的严重程度。将肝脏分为右后、右前、左内和左外 4 个部分。根据异常网状低增强的量,每个肝段的评分范围为 0 至 4 分。在 8 个连续动态对比增强改良扰相梯度回波运行中对每个肝段进行评分。将评分与临床和血流动力学参数相关联。
所有法洛四联症患儿的 MRI 均显示肝脏网状低增强,门静脉早期最严重,总灌注异常最大评分中位数为 12(范围:9-14)。在肝静脉期,所有灌注异常逐渐消退。与左肝叶相比,右肝叶的灌注异常评分更大(7 [范围:6-8] 比 5 [范围:3-6],P < 0.01)。与无影像学门静脉高压征象的患儿相比,左肝叶最大灌注异常评分最大的患儿(8 [范围:7-8] 比 4 [范围:3-5],P < 0.01)。高未结合胆红素和低血小板与更大的灌注异常相关(R = 0.450,P = 0.024 和 R = -0.458,P < 0.01)。MRI 时的年龄、法洛四联症后时间、局灶性肝脏病变和心脏 MRI 血流动力学参数与肝脏灌注异常的严重程度无显著相关性。
所有法洛四联症患儿的 MRI 均显示肝网状低增强异常,右肝叶最严重,在肝静脉期逐渐消退。门静脉高压患儿的左肝叶灌注异常更严重。